Bristol-Myers Squibb to close Irish plant


Bristol-Myers Squibb (BMS) is to close its manufacturing plant in Cruiserath, Ireland, with the loss of 130 jobs by the end of 2015. A further 30 positions will be cut at the nearby plant in Swords as one of several operating units on that site is also shuttered.

BMS tied the closures to ‘changing market demand’ for its products, along with efforts to optimise its manufacturing network. The remaining 320 employees at the Swords plant will continue to manufacture bulk pharmaceuticals.

Susan Hynes, BMS’s general manager of active pharmaceutical ingredient operations Ireland, said in a statement that ‘the company is working to explore potential future uses of the Cruiserath facility and will endeavour to minimise job losses in Ireland’.


Related Content

BMS sells OTC drugs for $482m

14 February 2013 Business

news image

Bristol-Myers Squibb will offload rights to a range of over-the-counter products to Reckitt Benckiser

Amylin headquarters to close with further job losses

4 April 2013 Business

news image

Bristol-Myers Squibb plans to shutter the San Diego, US, site following last year’s merger

Most Read

UC Davis chemist sentenced to four years over explosion

19 November 2014 News and Analysis

news image

Postdoc sentenced over attempt to make explosive device and reckless disposal of hazardous waste

Grad student blamed for research misconduct at Utah

13 November 2014 News and Analysis

news image

Two papers have been retracted due to image falsification at the University of Utah

Most Commented

Beetle behind breath test for bank notes

17 November 2014 Research

news image

Photonic crystal inks inspired by longhorn beetle could help to fight counterfeiting

Bayer wins race to buy Merck & Co consumer care

9 May 2014 Business

news image

$14bn deal will make Aspirin inventor the number two over-the-counter healthcare company